Trump Nominates Dr. Erica Schwartz for CDC Director Amid Agency Turmoil

President Donald Trump has announced his nomination of Dr. Erica Schwartz, a former deputy surgeon general from his first administration, to lead the Centers for Disease Control and Prevention (CDC), marking the latest attempt to bring stability to the embattled health agency.

A Decorated Military Medical Career

Dr. Schwartz brings over two decades of distinguished service across multiple uniformed services, including the U.S. Navy, Public Health Service Commissioned Corps, and U.S. Coast Guard. She served as deputy U.S. surgeon general during Trump's first term before departing in 2021.

"Erica graduated from Brown University for College and Medical School, and served a distinguished career as a Doctor of Medicine in the United States Military, the Greatest and Most Powerful Force in the World," Trump wrote on Truth Social, calling her "a STAR!"

Schwartz's impressive academic credentials include a bachelor's degree in biomedical engineering and medical degree from Brown University, a master's degree in public health from the Uniformed Services University of the Health Sciences, and a law degree from the University of Maryland.

CDC Leadership Crisis

The nomination comes as the CDC has faced unprecedented leadership instability during Trump's second term. The agency has been without a permanent director since August, cycling through multiple acting directors in less than a year.

The administration's first choice, former Rep. Dave Weldon of Florida, was withdrawn in March 2025 after facing opposition from Republican senators. Officials then turned to career scientist Susan Monarez, who served as acting director for just one month before being dismissed following clashes with Health Secretary Robert F. Kennedy Jr. over vaccine policy.

Jim O'Neill subsequently served as acting director for several months, signing off on controversial changes to the childhood vaccination schedule before being replaced by NIH Director Jay Bhattacharya, who has been juggling both roles since February.

Kennedy's Health Team Assembly

Alongside Schwartz's nomination, Trump announced three other key health appointments:

• Sean Slovenski, a healthcare industry executive, as CDC's chief operating officer
• Dr. Jennifer Shuford, Texas Department of State Health Services commissioner, as chief medical director
• Dr. Sara Brenner, principal deputy FDA commissioner, as senior counselor for public health

Kennedy expressed enthusiasm about the nomination, posting on X that he looked forward "to working together to restore trust, accountability, and scientific integrity."

Vaccine Policy Controversies

Schwartz would inherit an agency embroiled in significant controversy over vaccine policy changes implemented under Kennedy's leadership. A Massachusetts federal judge recently halted many of the vaccine policy modifications made by Kennedy's handpicked CDC vaccine advisory panel, the Advisory Committee on Immunization Practices (ACIP).

The ruling, prompted by a lawsuit from the American Academy of Pediatrics and other medical organizations, also blocked the controversial overhaul of the childhood vaccination schedule that O'Neill had approved in January. The CDC has yet to appeal this decision.

In what health policy experts view as an attempt to circumvent the court ruling, Kennedy recently signed off on a new charter for ACIP this month.

Expert Perspectives

Dr. Demetre Daskalakis, former head of the CDC's National Center for Immunization and Respiratory Diseases who resigned in protest of Kennedy's policies, offered cautious optimism about the new team while expressing concerns about political interference.

"This is a team with great potential if political interference and the self interest of the secretary of health doesn't hamper their ability to deliver for the health of the country," Daskalakis stated.

Looking Ahead

If confirmed by the Senate, Schwartz will face the monumental task of stabilizing an agency that has experienced unprecedented turbulence and restoring confidence in America's premier public health institution. Her military background and previous experience in Trump's administration may prove valuable assets as she navigates the complex political and scientific challenges ahead.

The nomination represents Trump's ongoing effort to reshape federal health agencies according to his administration's priorities while attempting to address the leadership vacuum that has plagued the CDC throughout his second term.